Webinar | March 14, 2024

How To Identify And Quantify Adeno-Associated Virus Fill States Using Analytical Ultracentrifugation


Recombinant adeno-associated viruses (AAVs) are workhorses in gene therapy, acting as vectors to deliver genetic material. However, AAV preparations are a mixed bag. These viral packages, composed of a protein shell (capsid) encapsulating single-stranded DNA, come in various fill states. Empty capsids, partially filled capsids (missing some DNA), the ideal fully-packaged capsids (the drug itself), and even over-stuffed capsids (containing more DNA than intended) can all be present. To ensure gene therapy treatments are safe and effective, it's critical to identify and quantify these different AAV species.

Maruno et al. recently published a powerful method using sedimentation velocity analytical ultracentrifugation (SV-AUC) with multiwavelength detection to analyze AAV size distributions. This technique physically separates the AAV species through ultracentrifugation, allowing researchers to not only distinguish them but also determine their quantities. This webinar delves into how to implement this analysis to pinpoint the various fill states present in AAV preparations.

Key Takeaways:

  • Multiwavelength AUC analysis of AAV preparations offers a robust approach to identifying and quantifying different AAV fill states.
  • Explore the limitations of other techniques like SEC-MALS for characterizing AAV samples.
  • Gain insights into the usefulness of complementary methods like analytical CsCl density gradient analysis for AAV characterization.
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Outsourced Pharma